Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin vs Benzonatate vs Standard of Care for Chronic Cough in ILD
NCT07859839Phase 4Not yet recruiting
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Oct 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in chronic cough comparing Gabapentin, Benzonatate and Standard of Care (3 arms). Primary endpoint: Cough intensity at 8 weeks. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
gabapentinbenzonatate
03
Conditions
chronic cough
Beyond the preview
Go deeper on NCT07859839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07859839.